100 related articles for article (PubMed ID: 3804889)
1. Evolution, ecology and epidemiology of antibiotic resistance. Proceedings, Paul-Ehrlich-Gesellschaft für Chemotherapie and the British Society for Antimicrobial Chemotherapy. Bad Honnef (Bonn), 21-26 March 1986.
J Antimicrob Chemother; 1986 Oct; 18 Suppl C():1-264. PubMed ID: 3804889
[No Abstract] [Full Text] [Related]
2. Methodology and evaluation of in-vitro models of antimicrobial chemotherapy. Proceedings of a joint meeting, 27-29 March 1984, organized by the Paul-Ehrlich-Gesellschaft für Chemotherapie and British Society for Antimicrobial Chemotherapy.
J Antimicrob Chemother; 1985 Jan; 15 Suppl A():1-326. PubMed ID: 3980319
[No Abstract] [Full Text] [Related]
3. [To what extent L-asparaginase affects the tumor cells? Press information of the Sektion Onkologie der Paul-Ehrlich-Gesellschaft für Chemotherapie].
Munch Med Wochenschr; 1969 Sep; 111(37):Suppl 37:1+. PubMed ID: 5260991
[No Abstract] [Full Text] [Related]
4. Oxoid aura system as a semi-automated, standard antimicrobial susceptibility test method.
Grover M; Dimmer S; Rodger J
Br J Biomed Sci; 2001; 58(3):146-53. PubMed ID: 11575736
[TBL] [Abstract][Full Text] [Related]
5. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
Brauers J; Ewig S; Kresken M
Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
[TBL] [Abstract][Full Text] [Related]
6. Calculated parenteral initial treatment of bacterial infections: Intra-abdominal infections.
Eckmann C; Isenmann R; Kujath P; Pross A; Rodloff AC; Schmitz FJ
GMS Infect Dis; 2020; 8():Doc13. PubMed ID: 32373438
[TBL] [Abstract][Full Text] [Related]
7. Calculated parenteral initial therapy of bacterial infections: Bacterial meningitis.
Shah PM; Brodt R; Wichelhaus TA; Nau R
GMS Infect Dis; 2020; 8():Doc07. PubMed ID: 32373432
[TBL] [Abstract][Full Text] [Related]
8. Comment on: An assessment of the risks associated with the use of antibiotic resistance genes in genetically modified plants: report of the Working Party of the British Society for Antimicrobial Chemotherapy.
Goodyear KL;
J Antimicrob Chemother; 2004 Nov; 54(5):959; author reply 960. PubMed ID: 15448127
[No Abstract] [Full Text] [Related]
9. Calculated parenteral initial treatment of bacterial infections: Introduction and antibiotics.
Bodmann KF; Kresken M; Grabein B; Dohmen PM; Wilke M
GMS Infect Dis; 2020; 8():Doc19. PubMed ID: 32373444
[TBL] [Abstract][Full Text] [Related]
10. Calculated parenteral initial treatment of bacterial infections: Economic aspects of antibiotic treatment.
Wilke M; Hübner C; Kämmerer W
GMS Infect Dis; 2020; 8():Doc03. PubMed ID: 32373428
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001.
Kresken M; Hafner D; Schmitz FJ; Wichelhaus TA;
Int J Antimicrob Agents; 2004 Jun; 23(6):577-81. PubMed ID: 15194128
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of antibiotic resistance.
Palmer DL
J Med; 1980; 11(4):255-62. PubMed ID: 6943257
[TBL] [Abstract][Full Text] [Related]
13. Origins and evolution of antibiotic resistance.
Davies J
Microbiologia; 1996 Mar; 12(1):9-16. PubMed ID: 9019139
[TBL] [Abstract][Full Text] [Related]
14. Calculated parenteral initial treatment of bacterial infections: Respiratory infections.
Ott SR; Bodmann KF; Grabein B; Höffken G; Kolditz M; Lode H; Pletz MW; Thalhammer F
GMS Infect Dis; 2020; 8():Doc15. PubMed ID: 32373440
[TBL] [Abstract][Full Text] [Related]
15. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.
Spellberg B; Guidos R; Gilbert D; Bradley J; Boucher HW; Scheld WM; Bartlett JG; Edwards J;
Clin Infect Dis; 2008 Jan; 46(2):155-64. PubMed ID: 18171244
[TBL] [Abstract][Full Text] [Related]
16. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms, and clinical management.
Fraimow HS; Abrutyn E
Infect Dis Clin North Am; 1995 Sep; 9(3):497-530. PubMed ID: 7490430
[TBL] [Abstract][Full Text] [Related]
17. Calculated parenteral initial treatment of bacterial infections: Bone and joint infections.
Vossen MG; Gattringer R; Thalhammer F; Militz M; Hischebeth G
GMS Infect Dis; 2020; 8():Doc10. PubMed ID: 32373435
[TBL] [Abstract][Full Text] [Related]
18. [Ecology and epidemiological significance of infectious chemotherapeutic resistance].
Tschäpe H; Rische H
Beitr Hyg Epidemiol; 1974; 22():1-102. PubMed ID: 4462550
[No Abstract] [Full Text] [Related]
19. Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty.
Stahlmann R; Lode H
GMS Infect Dis; 2020; 8():Doc16. PubMed ID: 32373441
[TBL] [Abstract][Full Text] [Related]
20. Rational approach to limiting emergence of antimicrobial drug resistance.
Mbori-Ngacha DA
East Afr Med J; 1997 Mar; 74(3):187-9. PubMed ID: 9185420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
